Loading…

Helicobacter pylori Induces Increased Expression of Toll-Like Receptors and Decreased Toll-Interacting Protein in Gastric Mucosa that Persists Throughout Gastric Carcinogenesis

Background Toll‐like receptors (TLR) are essential for Helicobacter pylori (HP) recognition. Their role in the progression of gastric lesions leading to cancer is not established. Aim To evaluate for the first time in humans the expression of TLR2, TLR4, and TLR5, as well as the expression of other...

Full description

Saved in:
Bibliographic Details
Published in:Helicobacter (Cambridge, Mass.) Mass.), 2013-02, Vol.18 (1), p.22-32
Main Authors: Pimentel-Nunes, Pedro, Gonçalves, Nádia, Boal-Carvalho, Inês, Afonso, Luís, Lopes, Paula, Roncon-Albuquerque Jr, Roberto, Henrique, Rui, Moreira-Dias, Luís, Leite-Moreira, Adelino F., Dinis-Ribeiro, Mário
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Toll‐like receptors (TLR) are essential for Helicobacter pylori (HP) recognition. Their role in the progression of gastric lesions leading to cancer is not established. Aim To evaluate for the first time in humans the expression of TLR2, TLR4, and TLR5, as well as the expression of other related molecules in the entire sequence of gastric lesions. Methods Biopsy samples (n = 80, 48% HP+) from normal mucosa, HP gastritis, metaplasia, dysplasia or adenocarcinoma were obtained from 44 patients. mRNA quantification of TLR2, TLR4, TLR5, Toll‐interacting protein (TOLLIP), PPAR‐γ, NF‐κB, TNF‐α, COX‐1, COX‐2, and CDX‐2 was performed by real‐time RT‐PCR. TLR2, TLR4, and TLR5 protein expression was quantified by immunohistochemistry. Results When compared to normal mucosa (1.0 arbitrary unit (AU)), HP gastritis presented higher expression of TLR2 (2.23 ± 0.36 AU), TLR4 (1.92 ± 0.40 AU) and TNF‐α (2.14 ± 0.50 AU) and lower TOLLIP and PPARγ expression (0.72 ± 0.12 AU, p 
ISSN:1083-4389
1523-5378
DOI:10.1111/hel.12008